1. Home
  2. EYPT vs UXIN Comparison

EYPT vs UXIN Comparison

Compare EYPT & UXIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYPT
  • UXIN
  • Stock Information
  • Founded
  • EYPT 1987
  • UXIN 2011
  • Country
  • EYPT United States
  • UXIN China
  • Employees
  • EYPT N/A
  • UXIN N/A
  • Industry
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • UXIN Business Services
  • Sector
  • EYPT Industrials
  • UXIN Consumer Discretionary
  • Exchange
  • EYPT Nasdaq
  • UXIN Nasdaq
  • Market Cap
  • EYPT 741.0M
  • UXIN 713.3M
  • IPO Year
  • EYPT 2005
  • UXIN 2018
  • Fundamental
  • Price
  • EYPT $14.00
  • UXIN $3.43
  • Analyst Decision
  • EYPT Strong Buy
  • UXIN
  • Analyst Count
  • EYPT 6
  • UXIN 0
  • Target Price
  • EYPT $25.83
  • UXIN N/A
  • AVG Volume (30 Days)
  • EYPT 1.1M
  • UXIN 270.3K
  • Earning Date
  • EYPT 11-06-2025
  • UXIN 11-24-2025
  • Dividend Yield
  • EYPT N/A
  • UXIN N/A
  • EPS Growth
  • EYPT N/A
  • UXIN N/A
  • EPS
  • EYPT N/A
  • UXIN N/A
  • Revenue
  • EYPT $51,898,000.00
  • UXIN $340,011,237.00
  • Revenue This Year
  • EYPT N/A
  • UXIN $727.65
  • Revenue Next Year
  • EYPT N/A
  • UXIN N/A
  • P/E Ratio
  • EYPT N/A
  • UXIN N/A
  • Revenue Growth
  • EYPT 2.99
  • UXIN 45.02
  • 52 Week Low
  • EYPT $3.91
  • UXIN $3.13
  • 52 Week High
  • EYPT $14.91
  • UXIN $7.48
  • Technical
  • Relative Strength Index (RSI)
  • EYPT 58.99
  • UXIN 48.76
  • Support Level
  • EYPT $13.00
  • UXIN $3.24
  • Resistance Level
  • EYPT $14.04
  • UXIN $3.67
  • Average True Range (ATR)
  • EYPT 0.93
  • UXIN 0.27
  • MACD
  • EYPT -0.08
  • UXIN 0.01
  • Stochastic Oscillator
  • EYPT 62.87
  • UXIN 27.06

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

About UXIN Uxin Limited ADS

Uxin Ltd is an investment holding company. Along with its subsidiaries, the firm operates used car e-commerce platforms through its mobile applications and websites. It facilitates used car transaction services and financing solutions offered by third-party financing partners to buyers for their used car purchases. The company generates revenue through sales of the commission of salvage car sales, and interest income from the financial lease. The Group generates its revenues in China, and assets of the company are also located in China Area.

Share on Social Networks: